Evidence map›Paper›PMID 21097678›Full record

ArticleMolecular cancer research : MCR2010

NSAID inhibition of prostate cancer cell migration is mediated by Nag-1 Induction via the p38 MAPK-p75(NTR) pathway.

Shehla Wynne, Daniel Djakiew

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cancer research : MCR, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. NSAIDs and Cancer Resolution: New Paradigms beyond Cyclooxygenase.International journal of molecular sciences · 2022
    Review
  6. Article
  7. Continuous flow asymmetric synthesis of chiral active pharmaceutical ingredients and their advanced intermediates.Green chemistry : an international journal and green chemistry resource : GC · 2021
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. p75NTR promotes survival of breast cancer resistant cells by regulating Bcl-2/Bax and MAPK pathway.International journal of clinical and experimental pathology · 2017
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Shehla WynneDepartment of Biochemistry and Molecular and Cellular Biology, Georgetown University Medical Center, 3900 Reservoir Road NW, Washington, DC 20057, USA.
Daniel Djakiew
Georgetown University · USGeorgetown University Medical Center · US

Funding

NGF RECEPTOR REGULATION OF PROSTATE GROWTHR01DK052626 · NIDDK · GEORGETOWN UNIVERSITY · PI DJAKIEW, DANIEL · 1999 to 2006
$1.5M
NGF Receptor Regulates Prostate GrowthR56DK052626 · NIDDK · GEORGETOWN UNIVERSITY · PI DJAKIEW, DANIEL · 2009 to 2009
$400k
NIDDK NIH HHS DK52626NIDDK NIH HHS R01 DK052626NIDDK NIH HHS R56 DK052626
6 · The paper itself

Abstract

The nonsteroidal anti-inflammatory drugs (NSAID) R-flurbiprofen and ibuprofen have been shown to induce expression of p75(NTR) (neurotrophin receptor) in prostate cancer cell lines. p75(NTR), a tumor necrosis factor receptor superfamily member, is a proapoptotic protein that functions as a tumor suppressor in the human prostate. Expression of p75(NTR) is lost as prostate cancer progresses and is minimal in several metastatic prostate cancer cell lines. NSAIDs induce p75(NTR) through activation of the p38 mitogen-activated protein kinase (MAPK) pathway, with a concomitant decrease in cell survival. Here, we show that treatment with R-flurbiprofen and ibuprofen induces expression of the NSAID-activated gene-1 (Nag-1) protein, a divergent member of the TGF beta (TGF-β) family, in PC-3 cells. Using the selective pharmacologic inhibitor of p38 MAPK, SB202190, and p38 MAPK-specific siRNA (small interfering RNA), we show that Nag-1 induction following NSAID treatment is mediated by the p38 MAPK pathway. p75(NTR)-specific siRNA pretreatment shows that Nag-1 induction by NSAIDs is downstream of p75(NTR) induction. Decreased survival of NSAID-treated cells is rescued by p75(NTR)-specific siRNA but not by Nag-1 siRNA. Transwell chamber and in vitro wound healing assays demonstrate decreased cell migration upon NSAID treatment. Pretreatment of PC-3 cells with p75(NTR) and Nag-1-specific siRNA shows that NSAID inhibition of cell migration is mediated by Nag-1 and p75(NTR). These results demonstrate a role for Nag-1 in NSAID inhibition of cell migration, but not survival.

Indexed as

Anti-Inflammatory Agents, Non-SteroidalCell Line, TumorCell MovementFlurbiprofenGrowth Differentiation Factor 15HumansIbuprofenImidazolesMaleMAP Kinase Signaling SystemNerve Tissue Proteinsp38 Mitogen-Activated Protein KinasesProstatic NeoplasmsPyridinesReceptors, Nerve Growth FactorRNA, Small Interfering4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazoleAnti-Inflammatory Agents, Non-SteroidalFlurbiprofenGDF15 protein, humanGrowth Differentiation Factor 15IbuprofenImidazolesNerve Tissue ProteinsNGFR protein, humanp38 Mitogen-Activated Protein KinasesPyridinesReceptors, Nerve Growth FactorRNA, Small InterferingTransforming Growth Factor beta1

Identifiers

PMID21097678
PMCPMC3003770
OpenAlexW2112179971

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.